Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients, Published online: 26 April 2018; doi:10.1038/s41416-018-0074-1

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

https://ift.tt/2JrQdxI